key: cord-0299432-bv7ui85s authors: Arambepola, R.; Yang, Y.; Hutchinson, K.; Mwansa, F. D.; Doherty, J. A.; Bwalya, F.; Ndubani, P.; Musukwa, G.; Moss, W. J.; Wesolowski, A.; Mutembo, S. title: Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign date: 2021-09-22 journal: nan DOI: 10.1101/2021.09.16.21263705 sha: 877e6346c1fc0260acf1be123e802a30f49ebc89 doc_id: 299432 cord_uid: bv7ui85s Introduction: Despite gains in global coverage of childhood vaccines, many children remain undervaccinated. Vaccination campaigns also known as Supplemental Immunization Activity (SIA) are commonly conducted to reach those who are undervaccinated. However, reaching these children even during an SIA is challenging. We evaluated the effectiveness of an SIA in reaching zero dose children. Methods: We conducted a prospective study in 10 health center catchment areas in Southern province, Zambia in November 2020. About 2 months before the measles and rubella SIA we developed aerial satellite maps which were then used to enumerate and survey households. Zero dose children were identified during this exercise. After the SIA, households with zero dose children identified before the SIA were targeted for mop up vaccination and to assess if they were vaccinated during the SIA. A Bayesian geospatial model was used to identify factors associated with zero-dose status before the campaign and produce fine-scale prevalence maps. Models were used to identify factors associated with measles zero-dose children reached in the campaign and identify optimal locations for additional vaccination sites. Results: Before the vaccination campaign, 4% of children under 9 months were DTP zero-dose and 17% of children 9-60 months were measles zero-dose. Of the 461 measles zero-dose children identified before the vaccination campaign, 338 (73.3%) were vaccinated during the campaign, 118 (25.6%) were reached by a targeted mop-up activity. The presence of other children in the household, younger age, greater travel time to health facilities, and living between health facility catchment areas were associated with zero-dose status. Mapping zero-dose prevalence revealed substantial heterogeneity, both within and between catchment areas. Several potential locations were identified for additional vaccination sites. Conclusion: Fine-scale variation in zero-dose prevalence and the impact of accessibility to healthcare facilities on vaccination coverage were identified. Geospatial modeling can aid targeted vaccination activities. What is already known? 72 • In many low-and lower-middle income countries, improvements in routine childhood 73 vaccination coverage have stalled. 74 • An estimated 17 million children globally have not received any routine vaccinations 75 (zero-dose children). 76 • Zero-dose children, and those who have not received any doses of specific vaccines 77 such as measles, remain vulnerable to preventable diseases and can sustain 78 transmission in otherwise highly vaccinated populations 79 • A lack of understanding of the number and spatial distribution of zero-dose children 80 make targeting vaccination activities to reach this group challenging. 81 What are the new findings? 82 • Prior to a mass measles and rubella vaccination campaign, 17% of children younger 83 than 9 months of age in the study area had not received the DTP vaccine and 4% of 84 children 9 months or older had not received a measles-containing vaccine. 85 • Over a quarter of the children identified as not having received a measles-containing 86 vaccine before the measles and rubella mass vaccination campaign were not vaccinated 87 during the campaign. 88 • Geospatial models revealed substantial fine-scale variation in zero-dose status and 89 optimal locations for additional vaccination sites. 90 What do the new findings imply? 91 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. to substantial investment in childhood immunization services. However, in the past decade, 97 progress has stagnated and routine vaccination coverage has declined in many countries [1, 2] . 98 Widespread disruption to vaccine delivery due to the COVID-19 pandemic has compounded this 99 problem, with global coverage of the first dose of a diphtheria-tetanus-pertussis-containing 100 vaccine (DTP1) and first-dose of a measles-containing vaccine (MCV1) falling from 90% and 101 86% in 2019 to 87% and 84% in 2020, respectively [3, 4] . This stalling progress and disruption to 102 routine vaccination activities has resulted in pockets of unvaccinated and undervaccinated 103 communities. Communities where vaccination rates are below herd immunity thresholds are at 104 risk of outbreaks of vaccine-preventable diseases [5] [6] [7] . 105 These communities at risk of outbreaks are made up of children who missed some 106 vaccine doses as well as children who did not receive any routine vaccinations, the latter 107 referred to as zero-dose children. In practice zero-dose children are often defined as children 108 who have not received a DTP1 vaccine [8-10].There were an estimated 17 million zero-dose 109 children in 2020, the majority living in sub-Saharan Africa or conflict-affected areas [4, 9, 11, 12] . 110 Research on the "immunization cascade", which describes how children move from zero-dose 111 to fully vaccinated, suggests that in many low-and lower-middle income countries vaccine 112 coverage is polarized, with most children either receiving all or almost all vaccines, or few to 113 none [13] . In many countries, including Zambia, mass measles and rubella vaccination 114 campaigns are carried out with the aim of vaccinating children who have not received their 115 routine doses. Understanding the prevalence and spatial distribution of children in the 116 community who have received few vaccines or are zero-dose is challenging, as these children 117 are likely to be less engaged with routine healthcare services [14] . Additionally, it can be difficult 118 to determine if underserved communities were reached after mass vaccination campaigns. 119 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. zero-dose in the initial household enumeration (children who were eligible for but had not 143 received any dose of a measles-containing vaccine) to identify which measles zero-dose 144 children were vaccinated during the campaign and vaccinate those who were not. We then 145 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We conducted a prospective study to quantify the vaccination status of children before 161 and after a mass measles and rubella vaccination campaign conducted between 20 -29th 162 November 2020. Approximately 6 weeks prior to the campaign, all structures identified in the 163 study area using satellite imagery were visited by community health volunteers (CHVs) and 164 eligible children were registered. Children between 9 and 60 months of age were eligible to 165 participate, to match eligibility for the mass vaccination campaign. Data were also collected for 166 children below 9 months to gather information on DTP1 vaccination status. These data included 167 age, sex, and measles and rubella vaccination status for children 9 months and older or DTP1 168 vaccination status for children younger than 9 months. For the purposes of this study, a child 169 was defined as DPT zero-dose if they were younger than 9 months of age and had not received 170 DTP1 and measles zero-dose if they were 9 months or older and had not received any dose of 171 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The relationships between several factors and zero-dose status before the mass 197 vaccination campaign were initially assessed in univariate analyses. These factors were age, 198 travel time to the nearest health facility calculated using a friction surface [25] with underlying probability for a child of this age at this location. This underlying probability 217 was on a logit-scale as the sum of a linear contribution from covariates and a Gaussian process 218 over space 219 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Here were covariate values, was the Gaussian process term and 0 , were parameters to 221 be learned. The covariates included age, travel time to the nearest health facility, presence of 222 an older eligible child in the same household, presence of a younger eligible child in the same 223 household, whether the household was between facilities, and which health facility catchment 224 area the household was in. The Gaussian process term accounted for spatial variation driven by 225 unobserved factors and was given a Matern covariance structure parameterised by the range, 226 , and marginal variance, 2 . A household-level random effect, ℎ , was also included (where ℎ 227 was the household that child lived in) to account for repeated sampling from households 228 containing multiple eligible children. 229 The zero-dose prevalence model previously described, with a child being vaccinated in the 243 campaign modelled as a Bernouilli process based on an underlying probability. This probability 244 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. was modelled as the sum of a linear combination of covariates and a Gaussian process term, 245 again as in the zero-dose prevalence model. Here the covariates were age and travel time to 246 the nearest campaign site. Campaign sites were defined as health facilities or outreach 247 vaccination sites. After fitting the model, the probability of a measles zero-dose child of a given 248 age and location being vaccinated in the campaign could be calculated. Let ( , ) be this 249 probability for a child of months of age at location . 250 To evaluate the effect of adding an outreach vaccination site at a given location , travel 251 times to the nearest campaign site were recalculated with this additional site included. The fitted 252 relationship was then used to calculate an updated probability, ^( , , )), of a measles zero-253 dose child of a given age at a given location being vaccinated in the campaign. We assumed 254 that individuals would not travel more than 60 minutes to be vaccinated and hence, the final 255 probability of a child being vaccinated given this additional vaccination site was defined to be 256 In other words, the total effectiveness of an additional site was defined as the increase in 263 vaccination probability of a child of a given age and location integrated over the empirical age 264 and spatial distribution of measles zero-dose children. The effect of adding multiple additional 265 outreach vaccination sites at different locations was similarly calculated by recalculating the 266 travel times and vaccination probabilities. 267 An alternative form of the geospatial model for vaccination probability was also fit in 268 which time to the nearest health facility and time to the nearest outreach vaccination site were 269 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. already more likely to be reached by the campaign, this could inflate the apparent effect of 294 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. interest (in this case whether a measles zero-dose child was vaccinated during the campaign) 297 but which is known or believed to be unaffected by the explanatory variable (in this case 298 distance to the nearest campaign site). The analysis is then repeated with this alternative 299 response variable and if the learned relationship with the explanatory variable is non-zero then it 300 suggests this analysis is confounded, and therefore the main analysis may also be confounded. 301 We used measles zero-dose status before the campaign, which clearly could not be affected by 302 the campaign itself, as a negative control to investigate any potential confounding. 303 In total, 41,952 structures were identified within the study area from aerial satellite 307 imagery. Of these, 10,758 households were eligible for the study (with many households 308 consisting of multiple structures). In the pre-campaign enumeration phase, 13,519 children were 309 registered and eligible for the study, of whom 1,870 (13.8%) were younger than 9 months and 310 11,649 (86.2%) were 9-60 months old (Figure 2 ). Of the children younger than 9 months, 322 311 (17.3%) had not received DTP1 and were therefore classified as DTP zero-dose children. Four 312 hundred and seventy (4.3%) children 9-60 months of age had not received MCV1 and were 313 classified as measles zero-dose. 314 Approximately one week after the mass measles and rubella vaccination campaign, 461 315 of the measles zero-dose children identified in the pre-campaign enumeration were successfully 316 followed up as part of a targeted mop up activity. Of these, 338 (73.3%) received the measles 317 and rubella vaccine during the campaign, 118 (25.6%) were vaccinated during this mop up 318 activity, and 5 (1.1%) remained unvaccinated. During these mop up activities, some of DTP 319 zero-dose children identified in the initial survey were also followed-up and some additional 320 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.16.21263705 doi: medRxiv preprint children were registered, although this was not the focus of the CHVs and was carried out in a 321 non-systematic way, detailed in Supplementary material section 1. 322 There was substantial heterogeneity in DTP and measles zero-dose prevalence prior to 323 the mass vaccination campaign at the health facility catchment-level ( Table 1) All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.16.21263705 doi: medRxiv preprint decreased as age increased, and initially increased as travel time to the nearest health facility 338 increased (Figure 3a, 3c) . As travel time increased further, DPT zero-dose prevalence 339 increased but measles zero-dose prevalence plateaued, although in both cases there was 340 substantial uncertainty at these distances due to small numbers of observations. DTP and 341 measles zero-dose prevalence was higher in children living in a household between facilities or 342 with other eligible children, with both effects stronger for measles zero-dose status. The 343 proportion of measles zero-dose children vaccinated during the mass vaccination campaign 344 decreased as travel time to the nearest vaccination site increased (Figure 3d) . 345 When the joint relationship between these factors and DTP zero-dose prevalence was 346 investigated using the geostatistical model, we found broadly similar results to the univariate 347 analyses. An increase in age and the presence of another younger eligible child in the 348 household were associated with increased DTP zero-dose prevalence ( Table 2) The effects of 349 the other covariates were uncertain, with the 95% credible intervals containing zero (Table 2) . 350 The magnitude of coefficient for age was particularly large, reflecting the initial steep decline in 351 DTP zero-dose prevalence with age ( Figure 3 ). There was no clear association between most 352 health facility catchment areas and DTP zero-dose prevalence except for Kamwanu and 353 Nalituba, which were associated with increased and decreased prevalence, respectively. 354 355 preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The results of the geostatistical model of measles zero-dose prevalence were also 361 similar to the univariate analyses. Measles zero-dose prevalence decreased with age (at a 362 slower rate than DTP zero-dose prevalence), while an increase in travel time to the nearest 363 facility and the presence of an older eligible child in the household were both associated with 364 increased measles zero-dose prevalence. The posterior mean for the effect of a household 365 being between facilities was also positive, although the 95% credible interval for this coefficient 366 narrowly contained zero. Batoka catchment was associated with lower measles zero-dose 367 prevalence while Masuku Mission and Mapanza catchments were associated with increased 368 prevalence. 369 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Many of the patterns in the maps of predicted zero-dose prevalence (Figures 4a and 4b ) 370 reflect the catchment-level patterns in the observed data, such as substantially higher DTP 371 zero-dose prevalence in Kamwanu and lower measles zero-dose prevalence in Batoka. There is 372 also subdistrict heterogeneity apparent in both maps, driven by the spatial covariates relating to 373 health facility access and trends in the observed data learned by the Gaussian process term in 374 the model. The model performed well under 10-fold cross validation (Figure 4c) , with 375 correlations between the observed and predicted prevalence at the settlement level of 0.632 376 and 0.534 for children younger than 9 months and 9 months and older respectively (see 377 supplementary material section 4 for details of additional validation). 378 Table 3 preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The optimal locations for three additional sites are shown in Supplementary Figure S7 406 and follow a similar pattern to optimizing the effect of a single site, with additional sites in 407 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Measuring routine childhood vaccination 578 coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global 579 Burden of Disease Study 2020, Release 1 WHO/UNICEF estimates of national immunization coverage Estimating global and regional disruptions to 584 routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling 585 study UNICEF. Vaccination and Immunization Statistics Critical Spatial Clusters for Vaccine Preventable 589 Diseases Network frailty and the geometry of herd 594 immunity Vaccination and herd immunity to infectious diseases All rights reserved. No reuse allowed without permission preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted Progress and Challenges with Achieving Universal Immunization 600 The Impact of Conflict on Immunisation Coverage in 16 Countries Zero-dose children and the immunisation 610 cascade: Understanding immunisation pathways in low and middle-income countries Challenges in measuring supplemental 613 immunization activity coverage among measles zero-dose children. Vaccine Risk factors for incomplete vaccination and missed 616 opportunity for immunization in rural Mozambique Reasons for incomplete vaccination and 619 factors for missed opportunities among rural Nigerian children Risk factors for incomplete vaccination 622 in children less than 18 months of age attending the nurseries of day-care centres in Sao Reasons why children miss vaccinations in 625 Western Kenya; A step in a five-point plan to improve routine immunization Reasons related to non-vaccination and under-628 vaccination of children in low and middle income countries: Findings from a systematic 629 review of the published literature Unvaccinated children in years of increasing 631 coverage: how many and who are they? Evidence from 96 low-and middle-income 632 countries All rights reserved. No reuse allowed without permission the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted Zambia Demographic and Health Survey Ministry of Health Zambia. Annual progress reports-Choma District Health Management 641 Team How do you ensure no one is missed by life-saving health services? A global map of travel time to cities to assess 645 inequalities in accessibility in 2015 Model-based geostatistics The effect of malaria control on Plasmodium 649 falciparum in Africa between Model-Based Geostatistics for Prevalence Mapping in Low-Resource Constructing Priors that Penalize the 653 Complexity of Gaussian Random Fields Ministry of Health Zambia Ministry of Health Zambia. Malaria Operational Plan Negative Controls: A Tool for Detecting 660 Confounding and Bias in Observational Studies Immunization coverage and risk factors for failure 662 to immunize within the Expanded Programme on Immunization in Kenya after introduction 663 of new Haemophilus influenzae type b and hepatitis b virus antigens Factors Influencing Childhood Immunization 666 Defaulters in Sabah, Malaysia. The International Medical Journal Malaysia All rights reserved. No reuse allowed without permission the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted The Contribution of Child Health Days to Improving Coverage of Periodic Interventions in Six African Countries The DHS Program -Quality information to plan, monitor and improve population, 674 health, and nutrition programs DHS Program Demographic and Health Survey. 675 This heterogeneity has important implications for disease control, as areas with a high 423 proportion of undervaccinated children may be at risk of outbreaks despite high coverage 424 overall (over 95% of children 9-60 months in the study had received MCV1 before the mass 425 vaccination campaign). The observed increase in zero-dose prevalence as travel time to the 426 nearest health facility increased suggests that travelling long distances may be an impediment 427 to vaccination, as has been previously observed [14, 18, 19] . This is also supported by the 428 decrease in proportion of measles zero-dose children vaccinated during the mass vaccination 429 campaign as distance to the nearest vaccination increased. There was also an apparent 430 increase in zero-dose prevalence in areas approximately equidistant from two health facilities 431 and this effect remained for children 9-60 months when controlling for other factors, including 432 travel time to the nearest facility. This may indicate that households in these areas are not being 433 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The presence of another eligible child in the household was also associated with 438 measles zero-dose children, we were able to compare the relative impact of adding one or more 456 vaccination sites in different locations. While real-world decision-making regarding planning and 457 targeting of future campaigns will depend on many additional factors, analyses such as these 458 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Therefore, zero-dose children who were not vaccinated during the campaign may also be 468 missed by these interventions. Thus, our approach is applicable to other child health 469interventions and campaigns. 470The household survey strategy described here provided a unique source of information 471 on the fine-scale spatial variation in the prevalence of zero-dose children. The process of 472 identifying structures via satellite imagery enabled data collectors to visit households that were 473 not previously known to the survey team and ensured that remote locations were included. In 474 contrast, routinely collected vaccination coverage data are collected at a more aggregated 475 spatial scale, such as at the health facility or district-level, and are therefore likely to mask some 476 of the fine-scale variation. Furthermore, the collection of routine data is likely to be biased 477 towards individuals or communities with better access to the healthcare system and therefore 478 may overestimate coverage. This can be seen in the high coverage values in many districts 479 (often above 100%) where true coverage is believed to be much lower [23, 36] . Another common 480 source of vaccination coverage data is from Demographic and Health Surveys (DHS) [37]; 481 however, these data are unable to provide the same level of spatial granularity as the data 482 analyzed here due to privacy-preserving spatial displacement and less dense sampling 483 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. However, the model may not perform as well in areas with substantially different geographic, 495 and demographic characteristics than Choma District. Further, we focused our analysis on 496 children identified as DTP or measles zero-dose, defined as those that had not received DTP1 497 or MCV1, respectively. This did not include children who were partially immunized, i.e., those 498 who received MCV1 but not MCV2, who may represent another partially susceptible population. 499Additionally, data were not collected on DTP1 vaccination status for children 9 months and 500 older, which would have allowed us to compare access to routine services more broadly. 501 502 CONCLUSION 503We provide one of the first spatial analyses of the prevalence of zero-dose children and 504 possible strategies to improve targeted and tailored measles and rubella vaccination activities. 505Our analysis indicates that greater travel time to healthcare (either health facilities or vaccination 506 sites) was associated with increased zero-dose prevalence and decreased likelihood of a 507 measles zero-dose child being vaccinated in the mass vaccination campaign. The presence of 508 other children in the household and living approximately equidistant from two health facilities 509 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. were also associated with greater zero-dose prevalence. The fine-scale spatial variation in zero-510 dose prevalence highlights the potential benefits of sub-district targeting and micro-planning of 511 vaccination activities and child health services more broadly. 512 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. before the campaign (middle, shaded in blue for households with any measles zero-dose 518 children) and households containing measles zero-dose children that were not vaccinated 519 during the campaign (right). 520 521 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Competing Interests: None declared. 566 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.